Meet us at ASN Kidney Week 2019

08. Oct 2019 | 3 min read

Meet us at ASN Kidney Week 2019

"Serum and plasma cystatin C measurement - a fast, easy and reliable estimation of renal function

Gentian at ASN Kidney Week 2019


We look forward to exhibit at ASN Kidney Week 2019 and we hope to see you in Washington, DC from November 7th to 9th  to discuss cystatin C and kidney health.

Cystatin C is a superior kidney marker and can be used to estimate GFR for patients independently of gender, weight and muscle mass. Cystatin C is recommended by KDIGO and NICE [1-3].

 

Visit us at booth #2133 - ASN Kidney week 2019


Gaute Tangen, Product Manager Cystatin C, and Shanyil Wickramasinghe, US Product Specialist, will be present at booth #2133 to tell you more about our cystatin C immunoassay and cystatin C in the clinical setting.

Want to know more? Book a meeting in advance through marketing@gentian.com

 

Gentian Cystatin C Immunoassay - FDA510(k) cleared

  • The Gentian Cystatin C Immunoassay is ERM-DA471 and IFCC standardised. The Gentian Cystatin C Immunoassay is FDA510(k) cleared and also CE-marked.

  • The immunoassay is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of cystatin C in human plasma and serum samples. It performs in 10 minutes.

  • The Gentian Cystatin C Immunoassay is used on a wide range of clinical chemistry analysers with documented high inter instrument accuracy [4].

Learn more about cystatin C

 

AACC WEBINAR ABOUT BIOMARKERS IN CHRONIC KIDNEY DISEASE:

The Use of Biomarkers in Chronic Kidney Disease and the Novel Disorder Shrunken Pore Syndrome

LEARN MORE ABOUT GENTIAN'S CYSTATIN C IMMUNOASSAY FOR PLASMA AND SERUM:

Gentian Cystatin C Immunoassay

INTERVIEW WITH DR. A. GRUBB – CYSTATIN C, GFR AND SPS:

Meet Dr. Grubb

 

References

[1] O.Z. Ismail, et al., 2017, http://dx.doi.org/10.1016/j.clinbiochem.2017.01.005

[2] Tangri N, et al Kidney Int 2011;79:471-7

[3] NCIC Clinical guideline (CG182) updated jan 2014 section 2.1  https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started

[4] Eckfeldt JH, et al. 2014 CYS Survey. Arch Pathol Lab Med 2015;139:888-93

You may also read


Collaboration Proposal - COVID-19

Apr 03, 2020

Collaboration Proposal - COVID-19

We at Gentian AS believe it is the duty of all companies in the health industry to help combat the ongoing..

Statement to Customers on COVID-19 Concerns

Mar 13, 2020

Statement to Customers on COVID-19 Concerns

At Gentian, the health and safety of our employees, as well as our customers and partners, is of primary..

New article about calprotectin in Scientific Reports

Mar 11, 2020

New article about calprotectin in Scientific Reports

Calprotectin, a new biomarker for diagnosis of acute respiratory infections*